Articles dans des revues avec comité de lecture (364)

  1. 298. Bron, D., Delforge, A., Lagneaux, L., De Martynoff, G., Bosmans, E., Van Der Auwera, P., Snoeck, R., Burny, A., & Stryckmans, P. (1990). Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV). Journal of immunological methods, 130(2), 209-216.
  2. 299. Delforge, A., Vandenplas, B., Lagneaux, L., Loos, M., Bron, D., Debusscher, L., & Stryckmans, P. (1990). Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors. European journal of haematology, 44(5), 307-311. doi:10.1111/j.1600-0609.1990.tb00400.x
  3. 300. Meunier, F., Van Der Auwera, P., Aoun, M., & Bron, D. (1990). Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia. British journal of haematology, 76(S2), 49-53. doi:10.1111/j.1365-2141.1990.tb07937.x
  4. 301. Henry-Amar, M., Hayat, M., Meerwaldt, J. H., Burgers, M., Carde, P., Somers, R., Noordijk, E. M., Monconduit, M., Thomas, J., Cosset, J., Van der Schueren, E., Regnier, R., Bron, D., Lutsman-Marechal, J., Tanguy, A., De Pauw, B., & Tubiana, M. (1990). Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. International journal of radiation oncology, biology, physics, 19, 1155-1157.
  5. 302. Sculier, J.-P., Bron, D., Sergijsels, R., & Klastersky, J. (1990). A pilot study with Ifosfamide, Carboplatin, and Etoposide regimen (ICE) in patients with advanced non small cell lung cancer. Clinical drug investigation, 2(1), 31-37.
  6. 303. Sculier, J.-P., Bron, D., Sergysels, R., & Klastersky, J. (1990). A pilot study with an ifosfamide, carboplatin and etoposide regimen (ICE) in patients with advanced non-small-cell lung cancer. Drug Investigation, 2(1), 31-37.
  7. 304. Stahel, R. A., Sculier, J.-P., Jost, L. M., Delforge, A., Bron, D., Gmür, J., Oelz, O., Sauter, C., Stryckmans, P., & Klastersky, J. (1989). Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. European journal of cancer & clinical oncology, 25(6), 965-972. doi:10.1016/0277-5379(89)90155-7
  8. 305. Sculier, J.-P., Bron, D., Delforge, A., Body, J.-J., Verboven, N., Fruhling, J., Stryckmans, P., & Klastersky, J. (1989). L'immunothérapie adoptive par interleukine-2. Premiers résultats d'une étude pilote chez 6 malades cancéreux. La Presse médicale, 18(23), 1155-1158.
  9. 306. Derycke, S., Demaubeuge, J., Laporte, M., & Bron, D. (1989). Déficit en prolidase à propos d'un cas. Annales de dermatologie et de vénéréologie, 116, 309-312.
  10. 307. Bron, D., & Regnier, R. (1989). Nouvelles stratégies dans le traitement de la maladie de Hodgkin. Patient care, 12, 14-22.
  11. 308. Philip, T., Armitage, J., Cahn, J.-Y., Hagenbeeck, A., Biron, P., Guilhot, F., Bron, D., Degliantoni, P., Manna, A., Santini, D., Sonneveld, P., Somer, R., Coiffier, B., Velasquez, W., & Chauvin, F. (1989). Pilot study of the DHAP rescue protocol and of a new conditioning regimen in responding NHL, at relapse. Bone marrow transplantation, 3, 81-83.
  12. 309. Bron, D., & Klastersky, J. (1989). Immunoprophylaxis of cytomegalovirus infections in transplanted patients. European journal of cancer & clinical oncology, 25(9), 1365-1368.

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 Suivant >>